API
< Back to situations

[ORGANIZATION]

University of Colorado Anschutz

Featured in 15 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [GB] [DE]

Expanding therapeutic uses and regulatory concerns for GLP-1

43 clusters · 180 sources · last updated

Latest: Semaglutide study shows BMI reduction in children with obesity

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

343 clusters · 1318 sources · last updated

Latest: FDA issues warning for GLP-1 drugs over vision loss risks

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt

[ACTIVE] [HEALTH] [BR] [ES] [US]

Research into peptide treatments for diabetic retinopathy

2 clusters · 5 sources · last updated

Latest: Researchers discover molecule that may protect vision from diabetes

Scientific research is advancing regarding peptide-based treatments to mitigate diabetic retinopathy. Initial studies conducted by researchers in Spain, involving the Complutense University of Madrid and the Fundación Ji

[QUIET] [HEALTH] [US]

HSV-1 impact on brain immune function

3 clusters · 10 sources · last updated

Latest: Herpes simplex virus type 1 linked to brain immune changes in Alzheimer study

Research published in PLOS Pathogens indicates that Herpes Simplex Virus type 1 (HSV-1) may alter the molecular functioning and genetic expression of microglia, the brain’s primary immune cells. Experimental studies on m

Also covered in